Healthcare Research Worldwide (HRW)’s Post

Have you signed up to HRW Synapse's exclusive webinar, 'Spark the Synapse: Neuromodulation Innovations Unveiled? By joining the teams webinar, you'll: 📝 Extend your current knowledge of neuromodulation across therapy areas. 👩🏫 Learn the current dialogue around neuromodulation including the benefits and drawbacks. 🏊 Dive into how neuromodulation might impact on the future treatment landscapes and the implications for pipeline pharmacological treatments. 🗣️ Hear about the topic from KoLs and patients through audio and video clips from interviews With limited spaces available, click the link below to learn more and register your place: https://lnkd.in/eq3AX2KV We look forward to seeing you there! #neuromodulation #innovations #synapse #neuroscience #neurology #therapyareas #futuretreatments #webinar #exclusivewebinar #freewebinar #webinars #educationalwebinar #pharma #pharmaceutical #pharmaceuticalmarketresearch #marketresearch

Traditionally preserved for later line, there is growing evidence to suggest earlier use of neuromodulation may offer huge benefits to patients. But what is the reality of this use of these tools today?   Join Catherine Harwood, Senior Director and Abigail Graham, Associate Director as they discuss how the future management of a variety of neurological conditions might evolve. With limited spaces available, click the link below to gurantee your spot: https://lnkd.in/eq3AX2KV We look forward to seeing you there! #neuromodulation #neurology #neuroscience #innovations #neurologicalconditions #webinar #exclusivewebinar #synapse #healthcare #healthcaremarketresearch #marketresearch #pharma #pharmaceutical #pharmamarketresearch #pharmaceuticalmarketresearch

❗ We’re excited to announce that HRW Synapse, our team of neuroscience experts, will be hosting their exclusive webinar, 'Spark the Synapse: Neuromodulation Innovations Unveiled', on Tuesday, 3rd December! 🧪 Traditionally, neuromodulation therapy has been reserved for later-line treatments. However, growing evidence suggests that using it earlier could help delay disease progression and complement pharmacological treatments. 💻 Join Catherine Harwood, Senior Director, and Abigail Graham, Associate Director, as they explore how the treatment landscape might evolve as neuromodulation becomes more commonplace. ⏰ With limited spaces available, click the link to find out more about this session and to register your space! https://lnkd.in/eq3AX2KV #webinar #synapse #neurology #neuroscience #neuromodulation #innovations #neurosciencewebinar #neuromodulation #freewebinar #complimentarywebinar #exclusivewebinar #exclusive #registrations #register #webinarregistrations #diseaseprogression #pharmaceuticaltreatments #pharmaceutical #pharma #pharmamarketresearch #pharmaceuticalmarketresearch #marketresearch #healthcaremarketresearch

‼️ With just under 2 weeks to go, spaces are filling up quickly! 🍿 To guarantee your place at HRW Synapse's FREE webinar 'Spark the Synapse: Neuromodulation Innovations Unveiled', click the link below: https://lnkd.in/eq3AX2KV 🤞 We hope to see you there! #neuromodulation #neuroscience #neurology #synapse #webinar #neuromodulationinnovations #innovation #healthcare #health #marketresearch #healthcaremarketresearch #research #webinar #freewebinar

Abigail Graham, Associate Director, recently attended the European Academy of Neurology 10th Annual Congress, held in Helsinki. This year’s theme, ‘Neuromodulation: Advances and Opportunities in Neurological Disease’, covered a range of topics, including new and upcoming treatments, precision medicine, and how future treatments are not purely pharmacological. Since the congress, Abigail has shared her key takeaways from the event. Scroll through the carousel below to find out more. If you would like to learn more about this year’s congress or have any specific questions relating to our neuroscience expertise, please reach out to the team at HRW_Synapse@hrwhealthcare.com #neuroscience #synapse #EAN2024 #EAN24 #EAN #EuropeanAcademyofNeurology #neurology #upcomingtreatments #treatmentsinneuroscience #neurologytreatments #precisionmedicine #pharmacological #keytakeawasy #neurologicaldisease #pharma #pharmaceutical #pharmamarketresearch #marketresearch #research #healthcare #healthcaremarketresearch

See below for Part 2 of an interesting dialogue between our Neuro Franchise Head Blaine Cloud and one of our advisory KOL's, Dr. Robert Naismith. You can build #strategy from our #marketresearch #insights, and #MakeBetterDecisions

#AI and structure-based drug discovery identify small molecule inhibitors of alpha-synuclein aggregation, a process implicated in #Parkinson’s disease. Learn how the work, which includes RT-QuIC assays on Omega Series microplate readers, pinpoints early-stage compounds with higher potency in less time and at lower cost. Read more: https://lnkd.in/epS2grty #fluorescence #machinelearning #drugdiscovery #neurology #compchem #protein misfolding

See below for Part 1 of an interesting dialogue between our Neuro Franchise Head Blaine Cloud and one of our advisory KOL's. This is just one of the ways that Spherix Global Insights is meaningfully different. You can build #strategy from our #marketresearch #insights, and #MakeBetterDecisions

Do you know that a well-functioning blood-brain barrier plays a critical role in maintaining our health? In this week's Ask the Experts Interview series, we hear from Jordan GUYON, the COO at Lys Therapeutics and Expert at Angelor. He shares more about his background and role in developing a first-in-class drug candidate for neurological diseases. Read the full article here: https://lnkd.in/gn2ZBbGm #neurology #biotech #lifescience #sejelas #asktheexperts #interviewseries

Were you able to attend our symposium about chronic insomnia yesterday? We presented new real-world evidence data at the 10th Congress of European Academy of Neurology in Helsinki yesterday afternoon with an expert panel of speakers: Anna Heidbreder (Austria), Yves Dauvilliers (France), Diego Garcia-Borreguero (Spain) and Claudio Liguori (Italy) on chronic insomnia and updated recommendations. If you missed it, please stop by our booth at E42 and we will be happy to provide you with the highlights. #EAN2024 #EANCongress #Pharmaceuticals #Neurology